GTPBP6, also known as GTP-binding protein 6, is a member of the GTPase superfamily, which are proteins known for their ability to bind and hydrolyze guanosine triphosphate (GTP). GTPases are pivotal regulators in the cell, acting as molecular switches that alternate between an active GTP-bound state and an inactive GDP-bound state. This switching mechanism is central to their role in controlling various cellular processes, including signal transduction, cytoskeletal organization, and vesicular transport.
While GTPBP6 shares homology with other GTPases, particularly within its GTPase domain, its specific cellular functions and mechanisms of action are not extensively characterized. The protein is conserved across different species, suggesting that it has a fundamental biological role. It is thought to be involved in the modification and maturation of transfer RNA (tRNA), a critical process for the proper functioning of protein synthesis. Through its interaction with the tRNA molecule, GTPBP6 may influence the accuracy and efficiency of translation by ensuring that tRNAs are correctly processed and modified.GTPBP6 may also play a role in cellular stress responses, particularly in the context of nucleolar stress, which can affect ribosome biogenesis and function. The protein's expression patterns and activity could be linked to the integrity of the cellular translational apparatus under conditions of stress or damage.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin can elevate cAMP levels, potentially affecting GTPase-mediated signaling pathways, thereby influencing GTPBP6. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
By activating AMPK, AICAR may modulate GTPase activity, potentially affecting GTPBP6. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
As a ROCK inhibitor, Y-27632 can influence GTPase signaling pathways, potentially impacting GTPBP6. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Lovastatin inhibits HMG-CoA reductase and may affect prenylation of GTPases, potentially impacting GTPBP6. | ||||||
GGTI 298 | 1217457-86-7 | sc-361184 sc-361184A | 1 mg 5 mg | $193.00 $838.00 | 2 | |
Inhibiting geranylgeranyltransferase with GGTI-298 affects GTPase activity, which might influence GTPBP6. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib, by inhibiting CDK4/6, might influence GTPase-mediated signaling pathways, indirectly affecting GTPBP6. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126, a MEK inhibitor, can impact MAPK/ERK signaling, potentially influencing GTPBP6 activity. | ||||||